Review Article
Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors
Table 4
Pancreatic cancer serum biomarkers identified after MS-based studies.
| Putative pancreatic cancer biomarker | Expression in pancreatic ca sera | References |
| Apolipoprotein CIII | Increased | [82] | Serum amyloid protein A | Increased | [83] | Apolipoprotein A-II | Decreased | [84] | Apolipoprotein A-I | Decreased | [84] | Transthyretin | Decreased | [84] | Alpha-2 macroglobulin | Increased | [85] | Ceruloplasmin | Increased | [85] | Complement 3C | Increased | [85] | Platelet factor 4 | Decreased | [86] | Mannose-binding lectin 2 | Increased | [87] | Myosin light chain kinase 2 | Increased | [87] | CXC chemokine ligand 7 | Decreased | [88] | TIMP1-ICAM1 | Increased | [89] | Alpha-1 antitrypsin | Increased | [90] | Fibrinogen gamma | Increased | [91] | C14orf166 | Increased | [92] | Alpha-1 antichymotrypsin | Increased | [93] |
|
|